Back

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: What is new on stroke prevention Oral Anticoagulation EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Julia Moser

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Left atrial thrombus in atrial fibrillation/flutter patients in relation to anticoagulation strategy: LATTEE registry
Doctor M. Gawalko (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Detection of atrial fibrillation in patients with cryptogenic stroke: The Nordic Atrial Fibrillation and Stroke (NOR-FIB) study - topline results
Doctor B. Ratajczak-Tretel (Sarpsborg, NO)
Abstract Slides Video
Presentation thumbnail
Oral anticoagulants in older patients with atrial fibrillation: insights from a nationwide study
Doctor P. Rasmussen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Adherence to oral anticoagulation in a Belgium atrial fibrillation population measured by a medical event monitoring system
Miss L. Knaepen (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Systolic blood pressure and effects of screening for atrial fibrillation with long-term continuous monitoring
Mr L. Xing (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
What is new on stroke prevention

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Presentation
State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources